KR920014473A - Crystalline sugar alcohol with uniformly dispersed fine particles of pharmaceutical compound - Google Patents

Crystalline sugar alcohol with uniformly dispersed fine particles of pharmaceutical compound Download PDF

Info

Publication number
KR920014473A
KR920014473A KR1019910000790A KR910000790A KR920014473A KR 920014473 A KR920014473 A KR 920014473A KR 1019910000790 A KR1019910000790 A KR 1019910000790A KR 910000790 A KR910000790 A KR 910000790A KR 920014473 A KR920014473 A KR 920014473A
Authority
KR
South Korea
Prior art keywords
composition
sugar alcohol
molten
sorbitol
alcohol
Prior art date
Application number
KR1019910000790A
Other languages
Korean (ko)
Inventor
윅스 듀로스 제임스
Original Assignee
로빈 이. 개쯔비
아이씨아이 아메리카스 아이엔씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로빈 이. 개쯔비, 아이씨아이 아메리카스 아이엔씨 filed Critical 로빈 이. 개쯔비
Priority to KR1019910000790A priority Critical patent/KR920014473A/en
Publication of KR920014473A publication Critical patent/KR920014473A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음No content

Description

제약학적 화합물의 미립자가 균일하게 분산 되어있는 결정형 당알콜Crystalline sugar alcohol with uniformly dispersed fine particles of pharmaceutical compound

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (13)

결정 매트릭스에 최소한 하나의 제약학적 활성 화합물의 입자가 균일하게 분산되어 있는 최소한 하나의 단당류 또는 다당류로부터 유도한 결정형 당 알콜로 이루어진 제약학적 조성물.A pharmaceutical composition comprising a crystalline sugar alcohol derived from at least one monosaccharide or polysaccharide in which particles of at least one pharmaceutically active compound are uniformly dispersed in a crystal matrix. 제1항에 있어서, 당 알콜이 소르비톨, 만니톨, 함께 결정화된 소르비톨과 만니톨, 크실리톨, 말티톨, 락티톨, 셀로비톨 및 수소첨가된 전분 가수분해물로 이루어진 그룹으로부터 선택된 조성물.The composition of claim 1 wherein the sugar alcohol is selected from the group consisting of sorbitol, mannitol, sorbitol and mannitol, xylitol, maltitol, lactitol, cellobiitol and hydrogenated starch hydrolysate crystallized together. 제1항에 있어서, 당 알콜이 소르비톨인 조성물.The composition of claim 1 wherein the sugar alcohol is sorbitol. 제1항에 있어서, 당 알콜이 함께 결정화된 소르비톨과 만니톨인 조성물.The composition of claim 1 wherein the sugar alcohols are sorbitol and mannitol crystallized together. 제4항에 있어서, 소르비톨이 약 5- 약 15중량%의 만니톨을 포함하는 조성물.The composition of claim 4 wherein the sorbitol comprises about 5- about 15 weight percent mannitol. 제1항에 있어서, 제약학적 활성 화합물이 알카리 및 알카리 토금속의 염 및 산화물; 철, 망간, 구리 및 아연의 미네랄 보충물; 아스파타민; 사카린; 페닐프로판올아민 HCL; 이부프로펜; 시메티딘; 아테놀올; 아세타미노덴 및 아스피린으로 이루어진 그룹으로부터 선택된 조성물.The compound of claim 1, wherein the pharmaceutically active compound is selected from salts and oxides of alkali and alkaline earth metals; Mineral supplements of iron, manganese, copper and zinc; Aspartamine; saccharin; Phenylpropanolamine HCL; Ibuprofen; Cimetidine; Athenol; A composition selected from the group consisting of acetaminodene and aspirin. 제1항에 있어서, 조성물이 정제 형태인 조성물.The composition of claim 1, wherein the composition is in tablet form. 제1항에 있어서, 조성물이 츄잉껌 형태인 조성물.The composition of claim 1 wherein the composition is in the form of chewing gum. (A) 최소한 하나의 단당류 또는 다당류로 부터 유도한 용융된 당 알콜을 만들고, (B) 균일 혼합물이 만들어지는 조건하에서 최소한 하나의 제약학적 활성 물질 입자를 용융된 당 알콜에 분산시키고, (C) 용융된 균일 혼합물을 저으면서 점성 매쓰가 생길 때까지 냉각시키고, (D) 당 알콜이 완전한 결정으로 될때까지 매쓰를 천천히 냉각시키는 단계로 구성되는, 제약학적 활성 화합물의 미립자가 균일하게 분산된 제약학적 조성물을 제조하는 방법.(A) to form a molten sugar alcohol derived from at least one monosaccharide or polysaccharide, (B) to disperse at least one particle of the pharmaceutically active substance in the molten sugar alcohol under the conditions under which a homogeneous mixture is made, and (C) A pharmaceutical composition with uniformly dispersed microparticles of the pharmaceutically active compound, consisting of stirring the molten homogeneous mixture while stirring until a viscous mass is formed, and (D) slowly cooling the mass until the sugar alcohol is a complete crystal. How to prepare. 제9항에 있어서, 활성 물질이 용융 알콜내에 각각 개별적인 입자로서 존재하는 방법.The method of claim 9, wherein the active substance is present as individual particles in the molten alcohol, respectively. 제10항에 있어서, 단계 B에서 활성 물질이 분말로 된 당 알콜과 미리 혼합된 혼합물 형태로 부가되는 방법.The process according to claim 10, wherein in step B the active substance is added in the form of a mixture previously mixed with powdered sugar alcohols. 제9항에 있어서, 활성 물질을 용융 알콜에 용해시키는 방법.The method of claim 9 wherein the active substance is dissolved in molten alcohol. 제9항에 있어서, 활성 물질을 용융 알콜에 용융시키는 방법.The method of claim 9 wherein the active material is melted in molten alcohol. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019910000790A 1991-01-18 1991-01-18 Crystalline sugar alcohol with uniformly dispersed fine particles of pharmaceutical compound KR920014473A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019910000790A KR920014473A (en) 1991-01-18 1991-01-18 Crystalline sugar alcohol with uniformly dispersed fine particles of pharmaceutical compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019910000790A KR920014473A (en) 1991-01-18 1991-01-18 Crystalline sugar alcohol with uniformly dispersed fine particles of pharmaceutical compound

Publications (1)

Publication Number Publication Date
KR920014473A true KR920014473A (en) 1992-08-25

Family

ID=67396514

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910000790A KR920014473A (en) 1991-01-18 1991-01-18 Crystalline sugar alcohol with uniformly dispersed fine particles of pharmaceutical compound

Country Status (1)

Country Link
KR (1) KR920014473A (en)

Similar Documents

Publication Publication Date Title
US5453283A (en) Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation
FI905781A0 (en) Process for the preparation of pharmaceutical compositions containing sugar alcohol and a homogeneously dispersed particulate active compound
KR890015733A (en) Antacid composition with long-term gastric retention time
US3085942A (en) Antitussive compositions and preparation
KR910011244A (en) Lozenge
KR950703935A (en) Pharmaceutical compositions that block taste
SE9200858D0 (en) PROCESS FOR THE PREPARATION OF SUSTAINED RELEADE PELLETS
KR910007516A (en) Presses containing sustained-release active compounds
KR950700049A (en) AGENT FOR REGULATING THE GREASINESS OF THE SKIN
KR920019346A (en) Vitamin D Stabilizers
CA2017045A1 (en) Method for preparing pulverized polydextrose which is substantially free of acids and compositions containing same
AP1769A (en) Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same.
KR960703566A (en) EFFERVESCENT GRANULATED MATERIAL AND METHOD FOR ITS PREPARATION
UA90253C2 (en) Non-tabletted, chewable, individually dosed administration forms
KR920014473A (en) Crystalline sugar alcohol with uniformly dispersed fine particles of pharmaceutical compound
US3883648A (en) Method of making stable granules of N-4-{8 2-(5-chloro-2-methoxybenzamido)-ethyl{9 -phenylsulfonyl-N{40 -cyclohexyl urea and its salts and process for preparing same
WO1990004962A1 (en) A pharmaceutical composition for rapid release of the active component comprising an orderred mixture and a surfactant
IE912040A1 (en) Amorphous gemfibrozil
ES2091093T3 (en) METHOD FOR THE MANUFACTURE OF A LAXANT COMPOSITION.
EP0366058A3 (en) Controlled-release delivery device, method for producing device, and method of using device
US4861591A (en) Formulations for hygroscopic pharmaceuticals
JPS6327049B2 (en)
DE3340347A1 (en) Use of flurbiprofen and ibuprofen
US5505963A (en) Slow release pharmaceutical preparation
EP0131950B1 (en) Quickly resorbable preparation of glibenclamide

Legal Events

Date Code Title Description
WITN Withdrawal due to no request for examination